Yes, one of the key advantages of nanotechnology in vaccine delivery is its potential for targeted delivery. Nanoparticles can be engineered to recognize and bind to specific cells or tissues, such as antigen-presenting cells (APCs). This targeted approach can enhance the uptake and processing of antigens, leading to a more efficient and robust immune response.
